BioSig Technologies, Inc. announced that it has entered into a security purchase agreement for the private placement of 1,665,384 shares, par value $0.001 per share at a price of $0.7806 per share for gross proceeds of $1,299,998.7504 on January 23, 2023. The transaction will include participation from accredited investor. The company has also issued warrants to purchase up to 832,692 shares, at an exercise price of $0.7181 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance.

The securities were offered and sold in reliance on the exemption from registration under the Securities Act of 1933, as amended provided by Section 4(a)(2) and Regulation D (Rule 506) under the Securities Act.